Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 21, 2021

SELL
$1.91 - $2.67 $191 - $267
-100 Closed
0 $0
Q3 2020

Oct 20, 2020

BUY
$1.81 - $5.53 $181 - $553
100 New
100 $0
Q4 2019

Jan 27, 2020

SELL
$2.05 - $2.82 $409 - $564
-200 Closed
0 $0
Q3 2019

Oct 17, 2019

BUY
$2.9 - $4.07 $580 - $814
200 New
200 $1,000

Others Institutions Holding GNCA

# of Institutions
1
Shares Held
10K
Call Options Held
0
Put Options Held
0

About GENOCEA BIOSCIENCES, INC.


  • Ticker GNCA
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,783,500
  • Description
  • Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...
More about GNCA
Track This Portfolio

Track Tci Wealth Advisors, Inc. Portfolio

Follow Tci Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.